By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters reported today an 8 percent increase in second-quarter revenues, which the firm partially attributed to "significantly improved" sales to pharmaceutical customers.

For the three months ended July 3, Waters said that revenues rose to $391.1 million, compared to $362.8 million in the year-ago period. Its net income increased 21 percent to $84.9 million, or $0.90 per share, from $70 million, $0.72 per share, in Q2 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.